{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 486407515
| IUPAC_name = ''N'',''N'',''N''-trimethyl-''N''-(3-phenylindol-1-yl)ethane-1,2-diamine
| image = Binedaline.png

<!--Clinical data-->
| tradename =  
| pregnancy_category =  
| legal_status = Uncontrolled
| routes_of_administration = Oral

<!--Pharmacokinetic data-->
| bioavailability =  
| metabolism =  
| elimination_half-life =  
| excretion =  

<!--Identifiers-->
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 60662-16-0
| ATC_prefix = none
| ATC_suffix =  
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C19H23N3/c1-20(2)13-14-21(3)22-15-18(16-9-5-4-6-10-16)17-11-7-8-12-19(17)22/h4-12,15H,13-14H2,1-3H3
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = SXYFFMXPDDGOEK-UHFFFAOYSA-N
| PubChem = 42509
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 2104611
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 38769
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 3AVG9P140R

<!--Chemical data-->
| C=19 | H=24 | Cl=1 | N=3 
| molecular_weight = 329.86696 g/mol
| smiles = c1cccc2c1c(cn2N(CCN(C)C)C)c3ccccc3
}}

'''Binedaline''' ('''Ixprim'''), also called '''binodaline''', is a [[drug]] that was being investigated as an [[antidepressant]] in the 1980s but never [[marketed]].<ref name="pmid6239991">{{Cite journal
| pmid = 6239991
| year = 1984
| author1 = Faltus | first2 = F.
| title = A controlled double-blind study comparing binedaline and imipramine in the treatment of endogenous depression
| volume = 12
| issue = 1
| pages = 34–38
| journal = Neuropsychobiology
| doi = 10.1159/000118107
| last2 = Geerling
}}</ref><ref name="isbn0-412-46630-9">{{cite book | author = David J. Triggle | title = Dictionary of Pharmacological Agents | publisher = Chapman & Hall/CRC | location = Boca Raton | year = 1996 | pages = | isbn = 0-412-46630-9 | oclc = | doi = | url = https://books.google.com/books?id=DeX7jgInYFMC&lpg=PA267&pg=PA267#v=onepage&q=&f=false}}</ref> It acts as a [[binding selectivity|selective]] [[norepinephrine reuptake inhibitor]] (K<sub>i</sub> = 25 nM), with relatively insignificant influence on the [[serotonin transporter|serotonin]] (K<sub>i</sub> = 847 nM) and [[dopamine transporter|dopamine]] (K<sub>i</sub> >= 2 µM) [[membrane transport protein|transporter]]s.<ref name="pmid2540319">{{Cite journal
| pmid = 2540319
| year = 1989
| author1 = Morin | first2 = R. | first3 = S. | first4 = J. P.
| title = Pharmacological profile of binedaline, a new antidepressant drug
| volume = 249
| issue = 1
| pages = 288–296
| journal = The Journal of Pharmacology and Experimental Therapeutics
| last2 = Zini
| last3 = Urien
| last4 = Tillement
}}</ref> It has negligible affinity for the [[alpha-adrenergic receptor|α-adrenergic]], [[muscarinic acetylcholine receptor|mACh]], [[H1 receptor|H<sub>1</sub>]], or [[5-HT2 receptor|5-HT<sub>2</sub>]] [[receptor (biochemistry)|receptor]]s.<ref name="pmid2540319">{{Cite journal
| pmid = 2540319
| year = 1989
| author1 = Morin | first2 = R. | first3 = S. | first4 = J. P.
| title = Pharmacological profile of binedaline, a new antidepressant drug
| volume = 249
| issue = 1
| pages = 288–296
| journal = The Journal of Pharmacology and Experimental Therapeutics
| last2 = Zini
| last3 = Urien
| last4 = Tillement
}}</ref>

== References ==
{{Reflist}}

{{Antidepressants}}
{{Stimulants}}
{{Adrenergics}}

[[Category:Indoles]]
[[Category:Amines]]


{{Amine-stub}}
{{nervous-system-drug-stub}}